Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women

American Journal of Epidemiology

Volumn 145, Issue 11, 1997, Pages 1030-1038

  Zeleniuch Jacquotte, Anne ^a,c   Bruning, Peter F ^b   Bonfrer, Johannes M G ^b   Koenig, Karen L ^a   Shore, Roy E ^a   Kim, Mimi Y ^a   Pasternack, Bernard S ^a   Toniolo, Paolo ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

androgens; breast neoplasms; DHEAS; estrogens; testosterone

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD DONOR; BREAST CANCER; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; STATISTICAL MODEL; TESTOSTERONE BLOOD LEVEL;

EID: 0030912932     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009059     Document Type: Article

References (43)

1. Grattarola R, Secreto G, Recchione C, et al. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol 1974;118:173-8.
2. Secreto G, Toniolo P, Berrino F, et al. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 1991;51:2572-6.
3. Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. (Review). Anticancer Res 1994; 14:2113-17.
4. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
5. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993;259:633-8.
6. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsh CW, eds. Banbury report 8. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1981: 87-101.
7. Lonning PE, Helle SI, Johannessen DC, et al. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor binding protein-1 in postmenopausal breast cancer patients. Clin Endocrinol (Oxf) 1995;42:23-30.
8. McFadyen IJ, Forrest APM, Prescott RJ, et al. Circulating hormone concentrations in women with breast cancer. Lancet 1976;1:1100-2.
9. Adami HO, Johansson EDB, Vegelius J, et al. Serum concentrations of estrone, androstenedione and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci 1979;84:259-74.
10. Secreto G, Recchione C, Cavalleri A, et al. Circulating levels of testosterone, 17β-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 1983;47:269-75.
11. Hill P, Garbaczewski L, Kasumi F. Plasma testosterone and breast cancer. Eur J Cancer Clin Oncol 1985;21:1265-6.
12. Malarkey WB, Schroeder LL, Stevens VC, et al. Twenty-four hour pre-operative endocrine profiles in women with benign and malignant breast disease. Cancer Res 1977;37:4655-9.
13. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-6.
14. Wysowski DK, Comstock GW, Helsing KJ, et al. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-9.
15. Garland CF, Friedlander NJ, Barrett-Connor E, et al. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135: 1220-30.
16. Vermeulen A. The androgens. In: Gray CH, James VHT, eds. Hormones in blood, 3rd ed, vol 4. New York: Academic Press, Inc, 1983:349-61.
17. Seymour-Munn K, Adams J. Estrogenic effects of 5-androstene-3 beta, 17 beta-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinol 1983;112:486-91.
18. Bulbrook RD, Hayward JL, Spicer CC. Relation between urinary androgen and corticosteroid excretion and subsequent breast cancer. Lancet 1971;2:395-7.
19. Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479-81.
20. Zumoff B, Levin J, Rosenfeld RS, et al. Abnormal 24-hr mean plasma concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res 1981;41:3360-3.
21. Jones DL, James VHT. Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in blood and tissue: studies of normal women and women with breast or endometrial cancer. J Steroid Biochem 1987;26:151-9.
22. Bernstein L, Ross RK, Pike MC, et al. Hormone levels in older women: a study of postmenopausal breast cancer patients and healthy population controls. Br J Cancer 1990;61: 298-302.
23. Barrett-Connor E, Friedlander NJ, Khaw KT. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 1990; 50:6571-74.
24. Gordon GB, Bush TL, Helzlouer KJ, et al. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 1990;50:3859-62.
25. Toniolo P, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
26. Toniolo PG, Pasternack BS, Shore RE, et al. Endogenous hormones and breast cancer: a prospective cohort study. Breast Cancer Res Treat 1991;18:S23-S26.
27. Bruning PF, Bonfrer JMG, De Jong-Bakker M. Influence of ACTH on aminogluthimidine induced reduction of plasma steroids in postmenopausal breast cancer. J Steroid Biochem 1984;21:293-8.
28. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. IARC Scientific Publications No. 32. Lyon: International Agency for Research on Cancer, 1980.
29. Toniolo P, Koenig KL, Pasternack BS, et al. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 1994;3:47-50.
30. Micheli A, Muti P, Pisani P, et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol 1991;44:1055-61.
31. Hankinson SE, Manson JE, Spiegelman D, et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3 year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
32. Armstrong BG, Whittemore AS, Howe GR. Analysis of case-control data with covariate measurement error: application to diet and colon cancer. Stat Med 1989;8:1151-63.
33. Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Geiger SR, Astwood EB, Greep RO, eds. Handbook of physiology. Washington, DC: American Physiological Society, 1973:615-29.
34. Lipworth L, Adami HO, Trichopoulos D, et al. Serum steroid hormone levels, sex hormone-binding globulin and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996;7:96-100.
35. Armstrong BG. The effects of measurement errors on relative risk regressions. Am J Epidemiol 1990;132:1176-84.
36. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and cortico-steroid binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68.
37. Bonfrer JMG, Bruning PF, Nooijen WJ. A simple method for the measurement of the steroid fraction bound to sex-hormone bound globulin in serum. J Steroid Biochem 1989;33:227-31.
38. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 1990;27:532-41.
39. 4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol 1995;142:925-34.
40. Maggino T, Pirrone F, Velluti F, et al. The role of the endocrine factors and obesity in hormone-dependent gynecological neoplasias. Eur J Gynaecol Oncol 1993;14:119-26.
41. Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981;2:103-21.
42. Cauley JA, Gutai JP, Kuller LH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.
43. Newcomb PA, Klein R, Klein BEK, et al. Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology 1995;6:318-21.